Cornerstone Advisors (Washington)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cornerstone Advisors (Washington)'s LLY Position: Q3 2020 in Review
Cornerstone Advisors (Washington) reduced its Eli Lilly (LLY) stake by 1.5% in Q3 2020, selling an estimated $6.19K and leaving 2,624 shares worth $388K. The position accounts for 0.04% of the portfolio, ranked #58.
Cornerstone Advisors (Washington) first reported a position in LLY in Q1 2014 and has held it in 27 quarters since. The position peaked at $437K in Q2 2020. 1,774 funds tracked by Wall St. Rank hold LLY as of Q3 2020.
- Cornerstone Advisors (Washington) held 2,624 shares of Eli Lilly worth $388K as of Q3 2020.
- Cornerstone Advisors (Washington) sold 40 Eli Lilly shares in Q3 2020, an estimated $6.19K.
- Eli Lilly made up 0.04% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #58 holding.
- Cornerstone Advisors (Washington) first reported a position in Eli Lilly in Q1 2014 and has held it in 27 quarters since.
- Cornerstone Advisors (Washington)'s Eli Lilly position peaked at $437K in Q2 2020.
- 1,774 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.
Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.